Leading Financial Service Provider in India | Canara Bank Securities Ltd

Concord Biotech Ltd.

Oct 08, 04:01 BSE 1350.00 ( -7.20 -0.53%)

Volume3425

Prev. Close
1357.20

Open Price
1361.40

Today's Low / High

1310.50 1368.75

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

987.05 1645.00

Oct 08, 03:57 NSE 1330.80( -28.90 -2.13%)

Volume181142

Prev. Close
1359.70

Open Price
1360.00

Today's Low / High

1309.50 1371.00

Bid Price (Qty.)1330.80 (1026)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

987.00 1647.80

Market Cap. ( ₹ in Cr. )	13922.32	P/BV	6.71	Book Value ( ₹ )	198.20
52 Week High/Low ( ₹ )	1648/987	FV/ML	1/1	P/E(X)	53.36
Book Closure	24/07/2026	EPS ( ₹ )	24.94	Div Yield (%)	0.57

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	10.00
No. of Equity Shares (in Lacs)	1046.16	1046.16	1046.16	1046.16	95.11

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	10.46	10.46	10.46	10.46	9.51
Total Share Capital	10.46	10.46	10.46	10.46	9.51

Reserves and Surplus	2006.60	1802.26	1516.18	1279.54	1093.71
Total Reserves and Surplus	2006.60	1802.26	1516.18	1279.54	1093.71
Total Shareholders Funds	2017.06	1812.72	1526.65	1290.00	1103.22
Minority Interest	-1.92	0.00	0.00	0.00	0.00

NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	6.24	31.25
Deferred Tax Liabilities [Net]	45.36	34.02	28.06	23.44	20.97
Other Long Term Liabilities	1.43	0.63	1.89	0.16	0.31
Long Term Provisions	3.72	2.82	1.96	2.30	1.87
Total Non-Current Liabilities	50.51	37.47	31.91	32.14	54.40

CURRENT LIABILITIES
Short Term Borrowings	0.00	0.38	6.23	25.00	29.34
Trade Payables	101.91	113.04	94.44	93.80	83.11
Other Current Liabilities	55.93	65.10	37.59	45.57	40.98
Short Term Provisions	11.23	5.54	3.90	27.48	1.75
Total Current Liabilities	169.08	184.06	142.16	191.84	155.17

Total Capital And Liabilities	2234.73	2034.25	1700.71	1513.98	1312.79

ASSETS
NON-CURRENT ASSETS
Tangible Assets	787.90	794.09	575.00	592.78	569.40
Intangible Assets	0.26	0.60	0.32	0.20	3.58
Capital Work-In-Progress	78.16	50.13	211.48	172.70	74.16
Intangible Assets Under Development	1.17	0.53	0.00	0.00	0.00
Fixed Assets	867.48	845.34	786.80	765.68	647.13
Goodwill On Consolidation	0.40	0.00	0.00	0.00	0.00
Non-Current Investments	88.58	18.73	2.06	0.12	0.26
Deferred Tax Assets [Net]	2.94	0.00	0.00	0.00	0.00
Other Non-Current Assets	25.22	34.94	15.62	20.48	32.74
Total Non-Current Assets	984.62	899.01	804.48	786.28	680.13


CURRENT ASSETS
Current Investments	402.06	316.54	243.70	136.93	73.47
Inventories	326.36	239.67	207.95	212.31	195.12
Trade Receivables	460.20	521.65	349.61	273.76	232.17
Cash And Cash Equivalents	13.58	1.18	47.02	43.45	88.93
OtherCurrentAssets	47.92	56.20	47.94	61.25	42.97
Total Current Assets	1250.11	1135.24	896.23	727.70	632.67

Total Assets	2234.73	2034.25	1700.71	1513.98	1312.79

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	31.60	26.67	26.75	26.59	91.70

BONUS DETAILS
Bonus Equity Share Capital	7.85	7.85	7.85	7.85	6.90

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	84.12	17.25	0.00	0.12	0.26
Non-Current Investments Unquoted Book Value	4.46	1.47	0.00	0.00	0.00

CURRENT INVESTMENTS
Current Investments Quoted Market Value	402.06	316.54	243.70	136.93	73.47

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	1.00
No. of Equity Shares (in Lacs)	1046.16

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	10.46
Total Share Capital	10.46
Reserves and Surplus	2006.60
Total Reserves and Surplus	2006.60
Total Shareholders Funds	2017.06
Minority Interest	-1.92
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00
Deferred Tax Liabilities [Net]	45.36
Other Long Term Liabilities	1.43
Long Term Provisions	3.72
Total Non-Current Liabilities	50.51
CURRENT LIABILITIES
Short Term Borrowings	0.00
Trade Payables	101.91
Other Current Liabilities	55.93
Short Term Provisions	11.23
Total Current Liabilities	169.08
Total Capital And Liabilities	2234.73
ASSETS
NON-CURRENT ASSETS
Tangible Assets	787.90
Intangible Assets	0.26
Capital Work-In-Progress	78.16
Intangible Assets Under Development	1.17
Fixed Assets	867.48
Goodwill On Consolidation	0.40
Non-Current Investments	88.58
Deferred Tax Assets [Net]	2.94
Other Non-Current Assets	25.22
Total Non-Current Assets	984.62
CURRENT ASSETS
Current Investments	402.06
Inventories	326.36
Trade Receivables	460.20
Cash And Cash Equivalents	13.58
OtherCurrentAssets	47.92
Total Current Assets	1250.11
Total Assets	2234.73
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	31.60
BONUS DETAILS
Bonus Equity Share Capital	7.85
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	84.12
Non-Current Investments Unquoted Book Value	4.46
CURRENT INVESTMENTS
Current Investments Quoted Market Value	402.06

Markets

Balance Sheet

BALANCE SHEET

Concord Biotech Ltd.